Leading U.S. cancer center selects RayStation for proton planning

09 Jan 2023
www.prnewswire.com
Radiation Therapy
STOCKHOLM, Jan. 9, 2023 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that The Ohio State University Comprehensive Cancer CenterCancer Center - Arthur G. James Cancer HospitalCancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), in the USA, has placed an order for the treatment planning system RayStation®*. Revenue from the order will be recognized in the fourth quarter, 2022.
The OSUCCC - James is the third largest cancer hospital in the USA and one of only 53 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in the nation. Further, Ohio State is the first hospital system to bring proton therapy to Columbus and the central Ohio area.
The department of Radiation Oncology will utilize a Varian ProBeam® 360 for proton therapy, and also has several Varian linear accelerators in service.
The OSUCCC - James will use the latest RayStation technologies, such as deep learning segmentation, image deformation, adaptive planning, multi-criteria optimization, and fallback planning, which allows for contingency planning and comparison of modalities to help clinicians select the most appropriate treatment technique.
Johan Löf, founder and CEO, RaySearch, says: "RaySearch is a leader in treatment planning for proton therapy and we are proud that yet another prominent proton clinic has selected RayStation. We look forward to supporting OSUCC - James in their clinical operation."
CONTACT:
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
Henrik Bergentoft, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
The following files are available for download:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.